ScholarIQanswers from OpenAlex

Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice

PaperCitations, authors & open-access status

Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice have?

ScholarIQcitation count

Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice has 352 citations in the OpenAlex counts ScholarIQ stores.

When was Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice published?

ScholarIQyear

Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice has 2009 year in the ScholarIQ index.

What is the open-access status of Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice?

ScholarIQoa status

Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice has bronze oa status in the ScholarIQ index.

What is the DOI of Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice?

ScholarIQdoi

The DOI for Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice is on the source record.

What is the PMID of Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice?

ScholarIQpmid

The PMID for Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice is on the source record.

What is the OpenAlex record for Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice?

ScholarIQopenalex

The OpenAlex for Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial